View Press Releases
-
LILLY RECEIVES MHRA MARKETING AUTHORISATION FOR ABEMACICLIB (VERZENIOS®▼) IN COMBINATION WITH ENDOCRINE THERAPY FOR ADJUVANT TREATMENT OF People with HR+, HER2- HIGH RISK EARLY BREAST CANCER
-
Four Well-Established Strategies Used in Hit Identification
A successful hit identification campaign relies on the use of a high-quality, diverse library of potential compounds to be screened, but also on capitalizing on other complementary techniques, such as structure-based virtual screening (SBVS) and fragment-based screening.
May 15, 2022
-
How to Synthesize Wax Esters? Three Synthetic Routes
Wax esters are esters formed by long-chain fatty acids and fatty alcohols. Owing to their biodegradability and good lubricity, wax esters can be used as base materials for advanced lubricants and advanced emollient oils for aviation, machinery, and chemical industries as well as for daily cosmetics and other fields. Wax esters can be divided into saturated and unsaturated types.
May 17, 2022
-
CD Formulation: How to Select Pharmaceutical Excipients
Pharmaceutical excipients refer to the substances used in the production and formulation of medicines. They perform multiple functions in pharmaceutical preparations and are likely to affect the quality, safety and effectiveness of drugs.
May 17, 2022
-
Alfa Chemistry Optimizes Its Microalgae Powder and Related Natural Extract Production Service
Deeply impressed by the huge potential of microalgae, Alfa Chemistry recently announced to optimize its production systems for microalgae powder and other related natural extracts. This service was first launched a few years ago and ever since then, it has gained over 75 patents in the fields of breeding, cultivation, processing and extract. With a team of biologists, engineers and technicians who are highly experienced with microalgae, the company decides to upgrade its production services by introducing more systematic procedures and more advanced equipment.
May 17, 2022
-
Alfa Chemistry Newly Releases the Offering of Forensic and Veterinary Standards
Through years of dedicated efforts, Alfa Chemistry has become one of the most popular suppliers of analytical reagents among customers across the globe. Chromatography standards are one of the best-selling categories among all products the company provides, and endeavors have never ceased to enrich such an offering. As a result, this month Alfa Chemistry announces that it has started to offer forensic and veterinary standards, another type of chromatography standards that could be used for forensic and veterinary research.
May 17, 2022
-
BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421, for Dry Eye Syndrome
BRIM Biotechnology, Inc. (“BRIM”), a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”), the world’s leading ophthalmic research organization for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM intends to initiate Phase 3 clinical studies with Ora’s support later this year.
May 16, 2022
-
Dotmatics supports Umicore Corporate R&D in processing of experimental data
-
N4 Pharma highlights potential of Nuvec® as gene therapy delivery platform
-
Gainwell Appoints Karen Shields as Chief Client Engagement Officer
-
VIDA Introduces New AI-Enabled Biomarker Services
New VIDA analysis packages & novel biomarkers empower trial sponsors to unlock breakthrough insights
May 16, 2022
-
BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
-
BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project
BioIVT is sourcing matched sets of cerebrospinal fluid, serum, and plasma from donors afflicted with ALS to further research of neurofilament in the blood as a biomarker for early stages of neurodegeneration.
May 15, 2022
-
Source the Best PseudoUridines at Industry-Renowned Exhibitions
BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022. With only a few days away, BOC Sciences sincerely invites all researchers concerned to pay a visit to its booths and have a constructive conversation with its knowledgeable experts.
May 13, 2022
-
Scale-Up Facilities and Leading Expertise Drive Commercial Fermentation Progress
BOC Sciences provides high-quality antibiotics, bioactive by-products, enzyme inhibitors, mycotoxins, and other fermented products as well as comprehensive CDMO services.
May 13, 2022
-
ArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Technology
ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment As a part of the LifeSphere® platform, this solution will be named LifeSphere Clarity and will unlock crucial data patterns leveraging machine learning Rapid, robust benefit-risk assessment is key for all organizations collecting and processing large safety data sets Intelligent tool will drive industry-wide advancement of pharmacovigilance and patient safety capabilities
May 11, 2022
-
Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM3 Study Focused on Closing Practice Gaps for Heart Conditions
The American College of Cardiology (ACC) is leveraging Biofourmis’ AI-based predictive analytics platform and virtual health navigators for ACC’s TRANSFORM(3) study. The study—which focuses on underserved populations with a history of healthcare disparities—will evaluate different intervention strategies for improving adherence to guideline-directed medication therapy (GDMT) for managing specific chronic cardiovascular conditions.
May 11, 2022
-
SeekGene Increases Efficiency by 500% by Leveraging MemVerge Memory Machine in the Cloud
SeekGene, a biotechnology research firm focusing on single-cell technology, has significantly reduced processing time and cost for data intensive single-cell analysis tasks using MemVerge Memory Machine running on AliCloud i4p compute instances. As a result, SeekGene is able to cut analytical time and costs significantly while optimizing their single-cell sequencing capabilities for researchers worldwide to promote faster development of precision medicine.
May 11, 2022
-
Absolute Antibody to be featured on “World’s Greatest!...” television series
-
NEWS RELEASE: Emmes launches Advantage eClinical
Please find below the latest news story from Emmes (CRO) announcing the launch of its Advanatge eClinical as a standalone cloud native clinical technology platform – after more than two years in development. Unusually, the new platform will be available to both Emmes and non-Emmes customers and aims to increase access to a suitable platform particularly for smaller biotechs. Should you have any questions or would like to run a Q&A around this news, please do let me know.
May 11, 2022